BioWorld Asia

Aug. 20, 2003

Chromosomal Breaks Could Hold Clues To Cancer Targets

Xenova Adding To Pipeline Via £8.5M KS Biomedix Acquisition

LONDON - Consolidation continues in the UK as Xenova Group plc announced an agreed-to £8.48 million (US$13.5 million) all-share takeover offer for KS Biomedix plc (KSB). (BioWorld International) Read More

Merck Drops Lead Molecule In Estrogen Program With Karo Bio

Codon Chair Says Company On Track Despite Turmoil At Top

BresaGen Moving Operations To U.S. For Better Biotech Climate

IsoTis Outlicenses Skin Product, Keeps Focus On Bone Programs

U.S., Others Formally Call For Panel On GMO Issue In Europe

Other News To Note

Today's news in brief

BioWorld

BioWorld briefs for Dec. 31, 2025.

Today's news in brief

BioWorld MedTech

BioWorld MedTech briefs for Dec. 31, 2025.

Illustration of magnifying glass looking at cancer in the brain

Researchers discover how glioblastoma tumors dodge chemotherapy

BioWorld MedTech

Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...

Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact

BioWorld

Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...

Big pharma taps fast Asia innovation in search of next Keytruda

BioWorld

Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...